DIA
Drug Information Association Logo
« Back to Listing

The Sites Have Spoken: Implementing Paperless Trials and Risk-Based Monitoring from a Site’s Perspective

Track:
Clinical Operations

Day & Time:
June 18, 8:00AM - 9:30AM (Pacific Standard Time)

Session Number:
302

Room Number:
3

Level:
Basic

Type:
Session

Title:
The Sites Have Spoken: Implementing Paperless Trials and Risk-Based Monitoring from a Site’s Perspective

Chair(s):
Penelope K. Manasco, MD, MS
Chief Executive Officer
MANA Consulting, United States

Description:
This session brings sites that have adopted paperless trials together to provide their opinions and insights into this new approach to clinical trial conduct.

Learning Objective(s):
Identify key factors for the successful adoption of paperless trials for investigative sites; Discuss key technology components and their setup that assist sites in the adoption of technology; Describe key training features that ensure adoption by the sites.

Presentation(s) & Speaker(s):
Site Satisfaction with a P3 Paperless Clinical Trial
Mary R. Flack, MD
CEO
Elevated Clinical Trials LLC , United States

A Site's Experience with Implementing Electronic Source
Catherine Morimoto
Director of Clinical Operations
Diablo Clinical Research, United States

Implementing eSource for Home Visits by Home Health Nurses
Teresa Suek
President
Research 3, Inc., United States